Amyloid-β-independent regulators of tau pathology in Alzheimer disease

R van der Kant, LSB Goldstein… - Nature Reviews …, 2020 - nature.com
The global epidemic of Alzheimer disease (AD) is worsening, and no approved treatment
can revert or arrest progression of this disease. AD pathology is characterized by the …

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

F Yin - The FEBS journal, 2023 - Wiley Online Library
Alzheimer's disease (AD) is an age‐associated neurodegenerative disorder with
multifactorial etiology, intersecting genetic and environmental risk factors, and a lack of …

Involvement of lipids in Alzheimer's disease pathology and potential therapies

H Chew, VA Solomon, AN Fonteh - Frontiers in physiology, 2020 - frontiersin.org
Lipids constitute the bulk of the dry mass of the brain and have been associated with healthy
function as well as the most common pathological conditions of the brain. Demographic …

Oxysterols: From cholesterol metabolites to key mediators

V Mutemberezi, O Guillemot-Legris… - Progress in lipid research, 2016 - Elsevier
Oxysterols are cholesterol metabolites that can be produced through enzymatic or radical
processes. They constitute a large family of lipids (ie the oxysterome) involved in a plethora …

Adeno-associated virus-based gene therapy for CNS diseases

M Hocquemiller, L Giersch, M Audrain… - Human gene …, 2016 - liebertpub.com
Gene therapy is at the cusp of a revolution for treating a large spectrum of CNS disorders by
providing a durable therapeutic protein via a single administration. Adeno-associated virus …

[HTML][HTML] Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment

R Loera-Valencia, J Goikolea… - The Journal of steroid …, 2019 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia and it is characterized by the
deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. However, the …

Cholesterol in brain disease: sometimes determinant and frequently implicated

MG Martín, F Pfrieger, CG Dotti - EMBO reports, 2014 - embopress.org
Cholesterol is essential for neuronal physiology, both during development and in the adult
life: as a major component of cell membranes and precursor of steroid hormones, it …

[HTML][HTML] Mitochondrial cholesterol: Metabolism and impact on redox biology and disease

L Goicoechea, LC de la Rosa, S Torres, C García-Ruiz… - Redox Biology, 2023 - Elsevier
Cholesterol is a crucial component of membrane bilayers by regulating their structural and
functional properties. Cholesterol traffics to different cellular compartments including …

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

JE Vance - Disease models & mechanisms, 2012 - journals.biologists.com
Dysregulation of cholesterol homeostasis in the brain is increasingly being linked to chronic
neurodegenerative disorders, including Alzheimer's disease (AD), Huntington's disease …

ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models

Y Zhao, D Hu, R Wang, X Sun, P Ropelewski… - Nature …, 2022 - nature.com
Predisposition to Alzheimer's disease (AD) may arise from lipid metabolism perturbation,
however, the underlying mechanism remains elusive. Here, we identify ATPase family AAA …